Cargando…
Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee
Triamcinolone acetonide extended-release (ER) 32 mg (Zilretta(®)) is approved in the USA for the management of osteoarthritis (OA) pain of the knee and is administered as a single, 5 mL intra-articular (IA) injection. Although the therapeutic effects from IA corticosteroids are typically short-lived...
Autores principales: | Paik, Julia, Duggan, Sean T., Keam, Susan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437125/ https://www.ncbi.nlm.nih.gov/pubmed/30847805 http://dx.doi.org/10.1007/s40265-019-01083-3 |
Ejemplares similares
-
Correction to: Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee
por: Paik, Julia, et al.
Publicado: (2019) -
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema
por: Fung, Simon, et al.
Publicado: (2022) -
Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery
por: Kang, Connie, et al.
Publicado: (2020) -
Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018) -
Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)